Apocynin

CAT:
804-HY-N0088-01
Size:
500 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Apocynin - image 1

Apocynin

  • Description:

    Apocynin is a selective NADPH-oxidase inhibitor with an IC50 of 10 μM[1][2]. Apocynin improves acute lung inflammation in Carrageenan (HY-125474) -induced pleurisy mice model[3]. Apocynin can also be used for cancer research[4]. Apocynin reverses the aging process in mesenchymal stem cells to promote osteogenesis and increases bone mass[5].
  • Product Name Alternative:

    Acetovanillone
  • UNSPSC:

    12352005
  • Hazard Statement:

    H315, H319, H335
  • Target:

    NADPH Oxidase
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Metabolic Disease; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/Apocynin.html
  • Purity:

    99.99
  • Solubility:

    DMSO : ≥ 100 mg/mL|H2O : 3.33 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    CC(C1=CC=C(O)C(OC)=C1)=O
  • Molecular Formula:

    C9H10O3
  • Molecular Weight:

    166.18
  • Precautions:

    H315, H319, H335
  • References & Citations:

    [1]Stolk J, et al. Am J Respir Cell Mol Biol, 1994, 11 (1), 95-102.|[2]Stefanska J, et al. Mediators Inflamm, 2008, 106507.|[3]Sun J, et.al. Apocynin suppression of NADPH oxidase reverses the aging process in mesenchymal stem cells to promote osteogenesis and increase bone mass. Sci Rep. 2015 Dec 21;5:18572. |[4]Yamasaki M, et.al. Selective inhibition by apocynin of the proliferation and adhesion to fibronectin of v-H-ras-transformed 3Y1 cells. Biosci Biotechnol Biochem. 2012;76 (6) :1177-81. |[5]Impellizzeri D et al. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol. 2011 Mar 1;81 (5) :636-48.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    Phase 1
  • CAS Number:

    [498-02-2]